Godavari Biorefineries Ltd (BSE: 544279, NSE: GODAVARIB) — Business Report / Investor Feed
Business & Distribution Evaluation — Godavari Biorefineries Ltd (BSE: 544279)
1. Business Identity
Godavari Biorefineries Ltd (GBL) is an integrated biorefinery transforming sugarcane-derived feedstock into sugar, ethanol, bio-based chemicals, consumer food products, and renewable power, serving domestic and international markets across 34+ countries [9][14]. The company is classified under Agricultural Food & Other Products — Sugar [11][39].
| Parameter | Detail |
|---|---|
| Year of incorporation | 1939 (as The Godavari Sugar Mills Limited) [8][60] |
| CIN | L67120MH1956PLC009707 [29][48] |
| Promoter group | Somaiya Group; Promoter entities: Samir Shantilal Somaiya, Somaiya Agencies Pvt Ltd, Sakarwadi Trading Co Pvt Ltd, Lakshmiwadi Mines & Minerals Pvt Ltd [39] |
| Promoter holding | 63.31% [as at Dec 31, 2025] [11] |
| Registered office | Somaiya Bhavan, 45/47, Mahatma Gandhi Road, Fort, Mumbai – 400 001 [20][48] |
| Manufacturing facilities | (1) Sameerwadi, Karnataka — integrated sugar, distillery, cogeneration; (2) Sakarwadi, Maharashtra — bio-based chemicals [8][60] |
| R&D centres | 3 DSIR-registered R&D facilities (Sakarwadi, Sameerwadi, Navi Mumbai) [12][51] |
| International offices | Hoofddorp, Netherlands; Philadelphia, USA [12] |
| IPO | Listed BSE/NSE on October 30, 2024; fresh issue of 92.33 lakh shares at ₹352/share, raising ₹325 Cr (fresh) + ₹229.75 Cr (OFS) = ₹554.75 Cr total [37] |
| Key subsidiaries | Solar Magic Pvt Ltd (India); Cayuga Investments B.V. (Netherlands); Godavari Biorefineries B.V. (Netherlands); Godavari Biorefineries Inc. (USA); Sathgen Therapeutics LLC (USA — drug discovery) [48][61] |
Historical evolution: Founded in 1939 as a sugar manufacturer; transitioned into chemical manufacturing using ethanol as feedstock in the 1960s; pivoted toward bio-based specialty chemicals and international markets from the 1990s under current CMD Samir Somaiya [60].
2. Revenue Architecture
Revenue Model Type
Hybrid: Product sales (sugar, chemicals, ethanol, consumer goods) + government-tender-based offtake (ethanol to OMCs) + power export to grid. Pricing is substantially influenced by government regulation — FRP/SAP for sugarcane input costs, MSP for sugar, and administered ethanol procurement prices set by OMCs [1][30]. Bio-based specialty chemicals operate on a relationship-driven, co-creation pricing model with global B2B customers [16][28].
Revenue from Operations (Consolidated)
| Metric | FY23 | FY24 | FY25 | 9M FY26 |
|---|---|---|---|---|
| Revenue from Operations (₹ Cr) | 2,000.28 (S) | 1,675.46 (S) / 1,686.67 | 1,853.17 (S) / 1,870.25 | 1,423.84 |
| EBITDA* (₹ Cr) | — | 147.9 / 133.77 | 120.3 / 103.88 | 47.2 |
| EBITDA Margin (%) | — | 8.8% | 6.4% | 3.3% |
| PAT excl. one-time deferred tax (₹ Cr) | — | 12.3 | 1.1 | — |
| PAT incl. one-time deferred tax (₹ Cr) | 12.00 (S) | 12.3 | (23.4) | (49.36) |
EBITDA includes Other Income. FY25 PAT includes one-time deferred tax impact of ₹24.5 Cr [49][21][35]
9M FY26 consolidated TOI reached ₹1,430.2 Cr, up 10.2% YoY (9M FY25: ₹1,290.74 Cr) [35][58]. Finance costs declined to ₹37.8 Cr (9M FY26) from ₹58.7 Cr (9M FY25), a ₹20.9 Cr reduction following ₹240 Cr term debt repayment from IPO proceeds [35][51].
Seasonality: H2 is structurally stronger — for the last 3 years, H2 EBITDA exceeded 100% of full-year EBITDA, reflecting sugarcane crushing season (November–April) [52].
Revenue Mix by Segment (Standalone, ₹ Crore)
Source: [2]. Three-year trend: Sugar 34%→33%→36%; Distillery 31%→33%→31%; Bio-chemicals 32%→30%→29% for FY23→FY24→FY25 [8].
Consolidated Segment Revenue — 9M FY26 vs 9M FY25 (₹ Cr)
Source: [35]
Segment Operating Profit (Standalone, ₹ Lakh) [FY25 vs FY24 — Audited]
Source: [47]. Bio-chemicals EBITDA grew >2× in FY25 [31]. Distillery segment EBIT margin declined to 2.55% in FY25 from >9% in FY23–FY24, driven by ~12% cane price hikes against stagnant ethanol prices and temporary ban on cane-to-ethanol diversion [58].
The dramatic inversion between Bio-based Chemicals (+452% operating profit) and Distillery (−72%) in FY25 signals a structural pivot: as specialty chemicals scale, the business is becoming less dependent on government-administered ethanol pricing — though ethanol still accounts for 31% of revenue.
Revenue by Customer Type
| Customer Type | Channel | Key Products |
|---|---|---|
| B2G | OMC tenders | Ethanol (anhydrous for blending programme) |
| B2B (Domestic) | Direct/institutional | Sugar (institutional), bio-chemicals, power (grid export) |
| B2B (Export) | Direct, advance payment basis | Bio-chemicals (ethyl acetate, specialty chemicals), sugar |
| B2C | Retail (Jivana brand) | Sugar, brown sugar, jaggery, turmeric, spices |
Pricing Mechanism & Pass-Through Ability
| Input/Product | Pricing Mechanism | Pass-Through Ability |
|---|---|---|
| Sugarcane procurement | FRP (₹315/q FY24 → ₹340/q FY25 → ₹355/q FY26, all at 10.25% recovery) [53] | None — regulated |
| Sugar selling price | Influenced by MSP and export quotas; ₹37.5–38/kg [Q4 FY25] [19] | Limited; GoM examining MSP increase [33] |
| Ethanol price | Government-administered: ₹65.61/L (juice), ₹60.73/L (B-heavy) — unchanged since Nov 2022 [53] | None; industry lobbying for price hike [36] |
| Bio-based specialty chemicals | Relationship-driven co-creation; few competitors | Relatively strong [16][28] |
Key margin squeeze: ~12% cumulative FRP hike over two seasons against zero ethanol price increase has compressed distillery profitability [58][53].
With ~64% of revenue (sugar + distillery) subject to government-administered pricing on both the input and output side, GBL's near-term margin trajectory hinges on policy decisions outside management control — particularly an ethanol price revision that the industry has been lobbying for since November 2022.
3. Product & Service Portfolio
Core Offerings
| Product Category | Key Products | Revenue Contribution | Lifecycle Stage |
|---|---|---|---|
| Sugar | Refined sugar, plantation white sugar, branded Jivana sugar | 36% of standalone revenue [FY25] | Mature |
| Distillery | Anhydrous ethanol, rectified spirit, ENA | 31% [FY25] | Growth (policy-driven) |
| Bio-based Chemicals | Ethyl acetate, bio-ethyl acetate, MPO, 1,3 butylene glycol, crotonaldehyde, acetaldehyde, bio-acetic acid, bio-butanol, EVE, paraldehyde, Naturowax | 29% [FY25]; Specialty = ~60% of this basket [FY25], rising to 62% [9M FY26] | Growth |
| Cogeneration | Renewable power (bagasse-fired; 45+ MW capacity) | ~3% [FY25] | Mature |
| Consumer (Jivana) | Sugar, brown sugar, jaggery (block & powder), turmeric, coriander, chilli powder, sugarcane concentrate | ₹108 Cr [FY25]; ₹100 Cr [9M FY26] | Growth (56% CAGR over 3 years) |
| Biotechnology (Sathgen) | Novel anti-cancer molecules (TNBC focus) | Pre-revenue; out-licensing stage | Early/R&D |
Sources: [2][8][14][40][43][59]
Key Differentiators
| Differentiator | Detail | Source |
|---|---|---|
| Only Indian manufacturer | Natural 1,3 butylene glycol; one of only 2 global producers | [15][43] |
| Only Indian plant | Bio-ethyl acetate, bio-butanol, paraldehyde production | [15] |
| First in India | Bio-based EVE manufacturing facility | [17][27] |
| Among world's leading | MPO manufacturer | [27] |
| 4th largest in India | Ethyl acetate manufacturer | [15] |
| Patent portfolio | 19 products/processes patented; 54 registrations across global jurisdictions; European anti-cancer patent validated in Spain, UK, and as Unitary Patent across EU; China patent for second anti-cancer molecule | [12][33][57] |
| R&D strength | 50+ research professionals including 9 doctorate-level scientists; 3 DSIR labs | [5][40] |
| Certifications | ISO 9001, ISO 14001, RC14001, REACH, ECOVADIS (Bronze, 62/100), ISCC Plus, Bonsucro (758+ farmers certified), USDA Bio-based, FSSC 22000, COSMOS, ECOCERT, Kosher, Halal, SMETA-4P | [15][42][44] |
| Sugar recovery | 10.94% [FY25] vs 10.78% [FY24] — above national average | [8] |
Specialty Chemicals Mix Shift
Bio-based specialty chemicals share within the chemicals segment: ~57% → ~60% [FY25] → 62% [9M FY26], with a stated objective to continue increasing this share [14][18][40]. This drove a >2× jump in chemicals segment EBITDA in FY25 [31].
Pipeline & Recent Launches
| Initiative | Status | Target Timeline | Capex | Source |
|---|---|---|---|---|
| 200 KLPD grain/maize distillery (Sameerwadi) | Under construction; progressing ahead of schedule | Q4 FY26 (commercial production by end CY25) | ~₹130 Cr (net of GST; GoI interest subvention loan) | [33][53][54] |
| Biobutanol & higher alcohols (Catalyxx license) | Exclusive India manufacturing license signed | Phase 1: 15,000 MTPA (of 30,000 MTPA); revenue potential ~₹250 Cr at full utilization | — | [34][50] |
| 1,3 Butylene Glycol debottleneck | Completed; 120 → 200 MT/month | Done [Jan 2025] | — | [22][34] |
| CO₂-to-DME pilot (with ICT Mumbai) | Pilot plant inaugurated; world's first one-step CO₂→DME process | Pilot stage | — | [10][26] |
| Bio-based butyl acrylate (Synthomer partnership) | Commercialisation underway using GBL's bio-butanol | In progress | — | [38] |
| SOP (Sulphate of Potash) recovery | Commissioning SOP unit from incinerator waste | In progress | — | [32] |
| Cancer drug — TNBC (Sathgen Therapeutics) | Phase 1a safety trials complete (no DLT); mechanism of action established; US subsidiary incorporated; SAB formed (Dr. Kurzrock, Dr. Cristofanilli) | Out-licensing target: 2–3 years | US$350,000 (Sathgen LLC capital) | [33][57][59][61] |
| 2G ethanol (from bagasse) | ₹150M JI-VAN Yojana grant secured | Research stage | — | [12][32] |
EBITDA Growth Target
Management has guided for 3× FY25 consolidated EBITDA by FY29 (i.e., ~₹300+ Cr from ~₹100 Cr base), driven by: (a) grain-based ethanol capacity addition, (b) specialty chemicals expansion and debottlenecking, and (c) biobutanol commercialisation. Major ethanol revenue growth expected in FY26–FY28 [31][54][46].
4. Value Chain Position
Position: Integrated processor & manufacturer — from sugarcane (agricultural feedstock) through to finished chemicals, fuels, sugar, food products, and renewable power.
Sugarcane Farmer → [GBL Crushing — 20,000 TCD] → Sugar → Branded Sugar (Jivana, B2C)
→ Molasses/Juice → Ethanol → OMCs (B2G)
→ Ethanol → Bio-based Chemicals → Global B2B
→ Bagasse → Power (Cogeneration) → Grid/Self
→ Press mud → Bhumilabh (bio-compost) → Farmers
→ Incinerator waste → SOP (Sulphate of Potash)
Grain/Maize → [200 KLPD Distillery — Q4 FY26] → Ethanol → OMCs / Chemicals
Direction of Integration
| Direction | Evidence |
|---|---|
| Backward | Supporting farmers via regenerative agriculture, Bonsucro certification (758+ farmers), soil testing, tissue culture, biofertiliser development via K.J. Somaiya Institute [12][42] |
| Forward | Consumer brand Jivana for retail sugar/food; Sathgen Therapeutics LLC (USA) for drug IP out-licensing; Synthomer partnership for bio-based butyl acrylate commercialisation [4][38][61] |
Key Inputs & Sourcing
| Input | Source | Concentration |
|---|---|---|
| Sugarcane | 85% locally sourced; crushing capacity only in Karnataka [13][41] | Concentrated in Karnataka — high-recovery belt (recovery ~10.94%) [8] |
| Grain/Maize | To be added via 200 KLPD facility [Q4 FY26]; corn widely grown in operating region [45] | Feedstock diversification to mitigate climate/policy risk [36] |
| Ethanol (internal) | Primary feedstock for bio-chemicals at Sakarwadi, Maharashtra | Internal transfer from distillery [41] |
Feedstock risk mitigation rationale: In FY24, the government suspended ethanol production from sugarcane juice due to poor monsoons, which impacted both crushing and ethanol volumes. The grain-based facility provides dual-feedstock flexibility against this climate and policy risk [36][45].
Circular economy model: Zero liquid discharge; 99% waste diverted from landfill; 84% renewable energy share [FY25]. By-products recycled: bagasse→power, molasses→ethanol, press mud→bio-compost, spent wash→steam/power, incinerator waste→SOP, boiler ash→bricks [13][32].
Capacity Summary
| Facility | Parameter | Current Capacity | Expansion |
|---|---|---|---|
| Sameerwadi (Karnataka) | Sugarcane crushing | 20,000 TCD [43][60] | Record 24.65 lakh tonnes crushed [SS 2024-25] [31] |
| Sameerwadi | Distillery (sugarcane) | 570 KLPD [55][60] | Env. clearance up to 1,000 KLPD [27] |
| Sameerwadi | Grain/maize distillery (upcoming) | 200 KLPD (~60 Mn litres/year) | Q4 FY26 commissioning [33] |
| Sameerwadi | Cogeneration | 45+ MW | — |
| Sakarwadi (Maharashtra) | Bio-based chemicals | Multiple product lines; 1,3 BG at 200 MT/month | Debottlenecking ongoing [31] |
| Sakarwadi | Biobutanol (Catalyxx license) | Phase 1: 15,000 MTPA → Phase 2: 30,000 MTPA | Q2 FY27 target [25][50] |
5. Distribution Architecture
Channel Structure
| Channel | Type | Key Products | Revenue/Scale Indicator |
|---|---|---|---|
| B2G (Government tender) | Direct — OMC tenders | Ethanol (anhydrous for blending) | Bid ~10 Cr litres; allotted ~7.5–8 Cr litres [FY25 cycle] [3] |
| B2B (Domestic institutional) | Direct sales force | Sugar (institutional), bio-chemicals, power | ~30-day collection period for institutional sugar [1] |
| B2B (Export) | Direct, with overseas offices | Bio-chemicals (ethyl acetate → Middle East, Africa, Europe), sugar | Exports to 34+ countries [9]; market development in 45+ countries [32]; advance payment basis [1] |
| B2C (Jivana brand) | General Trade + Modern Trade + E-commerce + Quick Commerce | Sugar, brown sugar, jaggery, turmeric, spices | ₹108 Cr [FY25]; ₹100 Cr [9M FY26] [14][26] |
Ethanol Distribution — B2G
Ethanol sales are entirely dependent on OMC tender allocations. Production is seasonal (November–April), with grain-based facility enabling year-round production from Q4 FY26 [10][36].
| Ethanol Metric | FY24 | FY25 |
|---|---|---|
| Production volume (KL) | 95,168 | 84,038 |
| Sales volume (KL) | 84,058 | 85,204 |
Source: [6]. FY25 production declined due to mid-year government ban on cane-to-ethanol diversion, subsequently restored [36].
Policy tailwind: India achieved 20% ethanol blending target 5 years early; guidelines for 27% blending announced [33]. Demand for ethanol remains robust even post-20% achievement [58].
Consumer Brand — Jivana (B2C Distribution)
Geographic presence [9M FY26]: 7 states — Maharashtra, Gujarat, Rajasthan, Madhya Pradesh (existing 4), plus Karnataka, Telangana, Andhra Pradesh (3 new states) [24].
Retail reach: 7,000+ outlets [H1 FY26] → 7,500+ outlets [9M FY26] [24].
Product expansion: Adding jaggery powder, turmeric, mirchi (chilli), dhaniya (coriander) [32][43].
Digital distribution [9M FY26]:
- Present on Zepto, Instamart, BigBasket, Flipkart, Minutes & Grocery platforms [24]
- Gross sales on Zepto increased 15× in one year of listing [24]
- Product ratings: 4.7 (178 ratings) on quick-commerce [26]
Bio-based Chemicals Distribution — B2B
- Co-creation model: Deep, collaborative partnerships; typical development cycle of 3–4 years per molecule through the funnel [28]
- Named clients: Hershey's India, Hindustan Coca-Cola, LANXESS, IFF, Synthomer [12][38]
- End-use industries served: Cosmetics, pharmaceuticals, agrochemicals, food, flavours & fragrances, coatings, solvents, personal care, green fuels [40][60]
- Export markets: USA, Germany, Japan, Australia, and 34+ countries; market development initiatives in 45+ countries [12][32]
- Export terms: Advance payment basis [1]
Network Scale
| Parameter | Detail |
|---|---|
| Manufacturing locations | 2 (Sameerwadi, Karnataka; Sakarwadi, Maharashtra) |
| International offices | 2 (Netherlands, USA) |
| US subsidiary (pharma) | Sathgen Therapeutics LLC, Princeton, NJ — incorporated Nov 17, 2025 [61] |
| Consumer retail outlets | 7,500+ [9M FY26] |
| Consumer state coverage | 7 states [9M FY26] |
| Export countries | 34+ (market development in 45+) |
Distribution Moat
| Segment | Moat Assessment |
|---|---|
| Ethanol | Limited moat — dependent on government tender process. However, scale (570 KLPD + 200 KLPD grain) and multi-feedstock capability provide competitive flexibility [27][36] |
| Bio-based specialty chemicals | Strong moat — co-creation relationships (3–4 year development cycles = high switching costs), unique Indian manufacturing capability for several molecules (1,3 BG, bio-ethyl acetate, EVE, biobutanol), global certifications (REACH, ISCC Plus, Bonsucro, COSMOS), and patent protection [15][28][33] |
| Consumer (Jivana) | Early-stage moat; rapid retail penetration and quick-commerce presence; brand still small relative to FMCG incumbents [24] |
| Biotechnology | IP-driven moat; patents in US, Europe, China; SAB with global oncology leaders; but pre-revenue and capital-light (US$350K investment) [57][61] |
GBL's competitive defensibility is bifurcated: the bio-based specialty chemicals business carries a genuine moat through co-creation lock-in and sole-manufacturer status for multiple molecules in India, while the sugar and ethanol businesses (67% of revenue) operate in commoditised, government-regulated markets with minimal differentiation.
6. Customer Profile
Customer Segments
| Segment | Revenue Type | Key Characteristics |
|---|---|---|
| Oil Marketing Companies (B2G) | Ethanol | Tender-based; government-administered pricing; seasonal; allotment ~7.5–8 Cr litres [FY25 cycle] [3] |
| Global corporates (B2B) | Bio-based specialty chemicals | Co-creation partnerships; long-cycle (3–4 years); named clients: Hershey's, HCC, LANXESS, IFF, Synthomer [12][38] |
| Institutional buyers (B2B) | Sugar, commodity chemicals | ~30-day credit; FSSC 22000, Kosher, Halal certified supply [1][42] |
| Export buyers (B2B) | Chemicals, sugar | Advance payment basis; 34+ countries [1][9] |
| Retail consumers (B2C) | Jivana brand products | 7,500+ outlets; 7 states; quick-commerce growth [24] |
Customer Concentration
Not specifically disclosed. The company does not report top-customer concentration percentages. Structural indicators:
- Ethanol sales are concentrated with OMCs — effectively a monopsony buyer channel [3]
- Bio-chemicals serve a diversified global base across 34+ countries with product customisation for international clients [12][32]
- The Jivana consumer brand provides further diversification away from institutional concentration
Relationship Depth
| Parameter | Detail |
|---|---|
| Bio-chemicals | Multi-year co-creation model; 3–4 year molecule development funnel; customers transitioning to lower carbon footprint co-create solutions with GBL [28][31] |
| Ethanol (OMC) | Annual tender cycle; dependent on government allocation and policy each season [7][36] |
| Sugar (institutional) | Steady ~30-day credit terms; year-round supply via inventory management [1] |
| Consumer (Jivana) | Repeat purchase; growing platform presence; strong online ratings (4.7/5) [24][26] |
| Synthomer (partnership) | Strategic partnership for bio-based butyl acrylate commercialisation — joint value creation [38] |
Acquisition Model
| Channel | Model |
|---|---|
| Ethanol | Government tender participation (B2G) [3] |
| Bio-chemicals | Co-creation with global customers; GBL presents solutions aligned with decarbonisation targets; also inbound demand from customers seeking bio-based alternatives [28][38] |
| Sugar | Institutional channel + government export quota allocations [23] |
| Jivana (consumer) | Channel-driven (GT/MT) + digital marketplace expansion + quick-commerce [24] |
| Biotechnology | Global out-licensing via US subsidiary; SAB-driven partnership development [59][61] |
Sector-Specific Metrics (Chemicals / Specialty + Sugar / Agri-Processing)
| Metric | Value | Period | Source |
|---|---|---|---|
| Sugarcane crushing (record) | 24.65 lakh tonnes | SS 2024-25 | [31][43] |
| Crushing capacity | 20,000 TCD | Current | [43][60] |
| Gross sugar recovery rate | 10.94% (vs 10.78% prior year; national avg ~9.30%) | FY25 | [8][53] |
| India sugar production estimate | 25.74 Mn tonnes (down from 31.54 Mn in FY24) | SS 2024-25 | [53] |
| India sugar forecast | 35 Mn tonnes (+15% YoY) | SS 2025-26 | [33] |
| FRP trajectory | ₹315→₹340→₹355 per quintal (at 10.25% recovery) | FY24→FY25→FY26 | [53] |
| Ethanol production | 84,038 KL | FY25 | [6] |
| Ethanol sales volume | 85,204 KL | FY25 | [6] |
| Current distillery capacity | 570 KLPD (sugarcane-based) | Current | [55][60] |
| Grain distillery addition | 200 KLPD = ~60 Mn litres/year | Q4 FY26 | [33] |
| Ethanol blending target (India) | 20% achieved; 27% guidelines upcoming | Current | [33] |
| 1,3 BG capacity | 200 MT/month (from 120 MT/month) | Post-Jan 2025 | [22] |
| Biobutanol licensed capacity | 30,000 MTPA (Phase 1: 15,000 MTPA); ~₹250 Cr revenue at full utilisation | Q2 FY27 target | [25][34] |
| Specialty chemicals share of bio-chem | ~60% [FY25] → 62% [9M FY26] | Rising trend | [40][14] |
| Renewable energy share | 84% | FY25 | [13] |
| Consumer brand (Jivana) outlets | 7,500+ | 9M FY26 | [24] |
| Consumer states coverage | 7 | 9M FY26 | [24] |
| Working capital cycle | 75–80 days (avg); year-end inventory 155–160 days | FY24–FY25 | [1] |
| Bonsucro certified farmers | 758+ | FY25 | [42] |
Segment Asset Allocation [FY25 — Audited, Standalone, ₹ Lakh]
Source: [47]. Bio-based chemicals and distillery are the most capital-efficient segments with significantly higher net assets relative to their asset base.
Sugar commands 40% of segment assets but generates near-zero net assets (₹858 lakh), while Distillery — with 31% of assets — produces ₹44,101 lakh in net assets. This stark capital efficiency gap underscores why management's 3× EBITDA target leans heavily on chemicals and ethanol expansion rather than sugar.
Key Data Gaps
- Customer concentration: No disclosure on single largest customer %, top 5 %, or top 10 % revenue concentration.
- Channel margin economics: No data on dealer/distributor margins, incentive structures, or channel financing terms for Jivana or institutional sugar channels.
- Geographic revenue split (domestic vs export): Not separately quantified in segment reporting; only qualitative references to 34+ (or 45+) export countries.
- Digital revenue share %: Jivana's online vs offline split not disclosed; only directional indicators (Zepto 15× growth).
- Competitive distribution comparison: Insufficient peer data in the filings to construct a side-by-side comparison with competitors (e.g., Balrampur Chini, Triveni Engineering, Dhampur Bio Organics).
- Sugar selling price realisation trend: Only a single data point (₹37.5–38/kg, Q4 FY25 [19]) available; no multi-year series.
- Ethanol pricing per litre by route (juice/B-heavy/C-heavy): Only current administered prices disclosed (₹65.61/L juice, ₹60.73/L B-heavy [53]); no trend since both unchanged since November 2022.
- Q3 FY26 consolidated segment P&L: H2 FY26 segment-level results partially available but OCR quality of some source documents is poor [56]; cross-referencing needed.